PRINCIPLES OF ANTIMICROBIAL THERAPy Flashcards

1
Q

lowest concentration of antibiotic

A. Minimum Inhibitory Concentration (MIC)
B. Minimal Bactericidal Concentration (MBC)

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

does not kill the organism

A. Minimum Inhibitory Concentration (MIC)
B. Minimal Bactericidal Concentration (MBC)

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

minimum concentration of antibiotic

A. Minimum Inhibitory Concentration (MIC)
B. Minimal Bactericidal Concentration (MBC)

A

B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

arrest the growth & replication of bacteria at serum level achievable in the patient, limiting the spread of infection

A. BACTERIOSTATIC DRUGS
B. BACTERICIDAL DRUGS

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

CHON synthesis inhibitors

A. BACTERIOSTATIC DRUGS
B. BACTERICIDAL DRUGS

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

→ kill the bacteria at drug serum level achievable in the patient
→ more aggressive

A. BACTERIOSTATIC DRUGS
B. BACTERICIDAL DRUGS

A

B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

cell wall synthesis inhibitors

A. BACTERIOSTATIC DRUGS
B. BACTERICIDAL DRUGS

A

B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

T/F

the hydrophobic molecule are concentrated in the cell bilayer
and cannot enter the cell

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

T/F

the hydrophilic molecules concentrate in the blood, cytosol, or
cytoplasm and easily enter the cell

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

→ antimicrobial action must be present at the wound site at the time of its closure
→ preventive treatment

A. PROPHYLACTIC TREATMENT
B. PRE-EMPTIVE TREATMENT
C. EMPIRIC TREATMENT
D. DEFINITIVE TREATMENT WITH KNOWN PATHOGEN
E. POST-TREATMENT SUPPRESSIVE TREATMENT

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

prophylaxis may be used to protect the healthy persons from acquisition of or invasion by specific organisms to which they are
exposed

A. PROPHYLACTIC TREATMENT
B. PRE-EMPTIVE TREATMENT
C. EMPIRIC TREATMENT
D. DEFINITIVE TREATMENT WITH KNOWN PATHOGEN
E. POST-TREATMENT SUPPRESSIVE TREATMENT

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

delivery of treatment prior to development of symptoms

A. PROPHYLACTIC TREATMENT
B. PRE-EMPTIVE TREATMENT
C. EMPIRIC TREATMENT
D. DEFINITIVE TREATMENT WITH KNOWN PATHOGEN
E. POST-TREATMENT SUPPRESSIVE TREATMENT

A

B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

early treatment for patients with lab tests indicating them as an asymptomatic patient

A. PROPHYLACTIC TREATMENT
B. PRE-EMPTIVE TREATMENT
C. EMPIRIC TREATMENT
D. DEFINITIVE TREATMENT WITH KNOWN PATHOGEN
E. POST-TREATMENT SUPPRESSIVE TREATMENT

A

B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

aborts impending disease

A. PROPHYLACTIC TREATMENT
B. PRE-EMPTIVE TREATMENT
C. EMPIRIC TREATMENT
D. DEFINITIVE TREATMENT WITH KNOWN PATHOGEN
E. POST-TREATMENT SUPPRESSIVE TREATMENT

A

B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

significant risk of serious morbidity

A. PROPHYLACTIC TREATMENT
B. PRE-EMPTIVE TREATMENT
C. EMPIRIC TREATMENT
D. DEFINITIVE TREATMENT WITH KNOWN PATHOGEN
E. POST-TREATMENT SUPPRESSIVE TREATMENT

A

C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

for patients with unknown origin of infection

A. PROPHYLACTIC TREATMENT
B. PRE-EMPTIVE TREATMENT
C. EMPIRIC TREATMENT
D. DEFINITIVE TREATMENT WITH KNOWN PATHOGEN
E. POST-TREATMENT SUPPRESSIVE TREATMENT

A

C

17
Q

drug of choice is influenced by the site of infection and history
of infection of the patient

A. PROPHYLACTIC TREATMENT
B. PRE-EMPTIVE TREATMENT
C. EMPIRIC TREATMENT
D. DEFINITIVE TREATMENT WITH KNOWN PATHOGEN
E. POST-TREATMENT SUPPRESSIVE TREATMENT

A

C

18
Q

T/F

In POST-TREATMENT SUPPRESSIVE TREATMENT initially, the disease is controlled by antimicrobial treatment and this treatment is continued at a lower dose if the infection is not yet completely eradicated

A

T

19
Q

patients with bacterial meningitis or endocarditis is given through?

A

IV

20
Q

patients with nausea and vomiting, gastrectomy, or disease that
may impair oral absorption is given through?

A

IV

21
Q

persistent suppression of microbial growth after levels of antibiotics have failed below MIC

A. Post-Antibiotic Effect
B. Time-Dependent Killing
C. Concentration-Dependent Killing

A

A

22
Q

acting only single or limited group of organisms

A. narrow-spectrum antibiotics
B. extended-spectrum antibiotics
C. broad-spectrum antibiotics

A

A

23
Q

effective against Gram (+) organisms and Gram (-)
organisms

A. narrow-spectrum antibiotics
B. extended-spectrum antibiotics
C. broad-spectrum antibiotics

A

B

24
Q

greater coverage for plenty of microbial species

A. narrow-spectrum antibiotics
B. extended-spectrum antibiotics
C. broad-spectrum antibiotics

A

C

25
Q

maximal level of antibiotic that can be tolerated by the host does not halt the growth of the pathogen

A

DRUG RESISTANCE

26
Q

indicated for individuals who are at high risk for temporary exposure to selected virulent pathogens & in patients who are at high risk for developing infection because of underlying disease (ex.: endocarditis)

A

NON-SURGICAL PROPHYLAXIS